# Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease

> **NCT03579693** · PHASE2 · COMPLETED · sponsor: **University of Washington** · enrollment: 26 (actual)

## Conditions studied

- Chronic Kidney Disease
- Sarcopenia
- Frailty

## Interventions

- **DIETARY_SUPPLEMENT:** CoQ10
- **DIETARY_SUPPLEMENT:** Nicotinamide riboside
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03579693
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-14
- **Primary completion:** 2021-04-26
- **Final completion:** 2021-04-26
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2023-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03579693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03579693, "Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03579693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*